ZP GENERAL PARTNER 1 ApS: Financial statements 2020
CVR: 36402660
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
ZP GENERAL PARTNER 1 ApS (CVR 36402660) has filed annual accounts for 2020. In 2020, the company reported revenue of USD 346,000 and a net result of USD 269,000 compared with USD -2,000 the year before. The profit margin was 77.7%. Equity in the 2020 report amounted to USD 609,000. The solvency ratio was 78.2%.
- Revenue
- USD 346,000
- Gross Profit
- USD 346,000
- Profit/Loss
- USD 269,000
- Equity
- USD 609,000
- Total Assets
- USD 779,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | 346 t. USD | 346 t. USD | 269 t. USD | 609 t. USD | - |
| 2019 | - | - | -2 t. USD | 12 t. USD | - |
| 2018 | - | - | -1 t. USD | 2 t. USD | - |
| 2017 | - | - | -2 t. USD | 3 t. USD | - |
| 2016 | - | - | -3 USD | 5 USD | - |
Official annual report
How creditworthy is ZP GENERAL PARTNER 1 ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
ZP GENERAL PARTNER 1 ApS has published its annual report for 2019. The net result was DKK -2,000.
As of May 29, 2020, EY Godkendt Revisionspartnerselskab has been appointed auditor of ZP GENERAL PARTNER 1 ApS.
As of May 29, 2020, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of ZP GENERAL PARTNER 1 ApS.
About ZP GENERAL PARTNER 1 ApS
ZP GENERAL PARTNER 1 ApS is a Danish company of the type Anpartsselskab based in Søborg, founded in 2014. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Adam Sinding Steensberg and Henriette Wennicke. The company is owned by ZEALAND PHARMA A/S. In 2025, the company reported revenue of DKK 2,000 and a net result of DKK -26,000 compared with DKK -14,000 the year before. Equity in the 2025 report amounted to DKK 81,000.